Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia

March 2000

The FDA just approved Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia.

This is the first antibiotic to be approved for this use.

Strep pneumoniae are becoming increasingly resistant to penicillins and other antibiotics.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

many patients are getting drug doses that are too high
Gastroenterology Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)
Cardiology whether vitamin E reduces the risk of coronary heart disease
Pediatrics Augmentin is more effective than Zithromax for acute otitis media
Pediatrics Prevnar, the first pneumococcal vaccine for children under 2
Ophthalmology three new eye drops for itching due to allergic conjunctivitis
counteract sexual dysfunction caused by SSRIs (Prozac, etc)
SSRIs can cause patients to clench and grind their teeth
Women's Health Ortho-Prefest, a new combo HRT regimen
Women's Health metformin and other insulin-sensitizing drugs for Polycystic Ovary Syndrome (PCOS)
which calcium supplement to recommend for a particular patient
Infectious Diseases Levaquin (levofloxacin) for treating penicillin-resistant pneumococcal pneumonia
Infectious Diseases Sporanox (itraconazole) now comes in IV form
drug interactions with St. John's wort